Home Eczema Creams and Lotions Eosinophilic Esophagitis and Dupilumab as a Potential NewTherapeutic | 2020 Research Retreat Eosinophilic Esophagitis and Dupilumab as a Potential NewTherapeutic | 2020 Research Retreat eczemanews Jul 01, 2023 comments off Tweet on Twitter Share on Facebook Pinterest Presented by Jennifer Maloney, MD, Executive Medical Director, Respiratory and Inflammation at Regeneron source